The Macau Metro Monitor. November 4th, 2009.



Macau’s gross gaming revenue recorded a new high last night at US$1.58 billion (MOP12.6 billion), an increase of 42% as compared with October last year, according to the Portuguese news agency Lusa.  Lusa said that provisional figures show that last month’s revenue was greater than the previous record month of August by some MOP1.4 billion.  The good performance in October was certainly aided by the “Golden Week” celebrations for the 60th anniversary of the founding of the People’s Republic of China.



Sands China, the Macau unit of Las Vegas Sands Corp that is hoping to raise US$2.5 billion in a Hong Kong initial share sale, said that earnings might rise 17% this year as casino revenues recover.  The company said, in a draft listing prospectus filed with the Hong Kong stock exchange, that adjusted EBITDAR would not be less than US$802.9 million this year, from US$686 last year.  Cost cuts and rising casino revenue in the third quarter have helped offset the impact of the global economic downturn, the outbreak of swine flu, and visa restrictions for mainland customers, the company said.  The draft prospectus said that Sands Macau’s profit may rise 9.5% to US$192.4 million this year.



Macau’s exports fell by 55% to MOP5.78 billion between January and September compared with the same period the previous year, according to the Statistics and Census Bureau (DSEC).  The DSEC also said that imports for the January to September reached MOP26.45 billion (US$3.3 billion), a fall of 19.3% compared to the value posted for the same period in 2008.  From January to September, exports to Macau’s main markets, the United States, the EU, and China, were down 79.3%, 59.6%, and 45.4%, respectively.

GOLD: A Deep Dive on What’s Next with a Top Commodities Strategist

“If you saved in gold over the past 20 to 25 years rather than any currency anywhere in the world, gold has outperformed all these currencies,” says Stefan Wieler, Vice President of Goldmoney in this edition of Real Conversations.

read more

Exact Sciences Up +24% This Week... What's Next? | $EXAS

We remain long Exact Sciences in the Hedgeye Healthcare Position Monitor.

read more

Inside the Atlanta Fed's Flawed GDP Tracker

"The Atlanta Fed’s GDPNowcast model, while useful at amalgamating investor consensus on one singular GDP estimate for any given quarter, is certainly not the end-all-be-all of forecasting U.S. GDP," writes Hedgeye Senior Macro analyst Darius Dale.

read more

Cartoon of the Day: Acrophobia

"Most people who are making a ton of money right now are focused on growth companies seeing accelerations," Hedgeye CEO Keith McCullough wrote in today's Early Look. "That’s what happens in Quad 1."

read more

People's Bank of China Spins China’s Bad-Loan Data

PBoC Deputy Governor Yi says China's non-performing loan problem has “pretty much stabilized." "Yi is spinning. China’s bad-debt problem remains serious," write Benn Steil and Emma Smith, Council on Foreign Relations.

read more

UnderArmour: 'I Am Much More Bearish Than I Was 3 Hours Ago'

“The consumer has a short memory.” Yes, Plank actually said this," writes Hedgeye Retail analyst Brian McGough. "Last time I heard such arrogance was Ron Johnson."

read more

Buffalo Wild Wings: Complacency & Lack of Leadership (by Howard Penney)

"Buffalo Wild Wings has been plagued by complacency and a continued lack of adequate leadership," writes Hedgeye Restaurants analyst Howard Penney.

read more

Todd Jordan on Las Vegas Sands Earnings

"The quarter actually beat lowered expectations. Overall, the mass segment performed well although base mass lagging is a concern," writes Hedgeye Gaming, Lodging & Leisure analyst Todd Jordan on Las Vegas Sands.

read more

An Update on Defense Spending by Lt. Gen Emo Gardner

"Congress' FY17 omnibus appropriation will fully fund the Pentagon's original budget request plus $15B of its $30B supplemental request," writes Hedgeye Potomac Defense Policy analyst Lt. Gen Emerson "Emo" Gardner USMC Ret.

read more

Got Process? Zero Hedge Sells Fear, Not Truth

Fear sells. Always has. Look no further than Zero Hedge.

read more

REPLAY: Review of $EXAS Earnings Call (A Hedgeye Best Idea Long)

Our Healthcare Team made a monster call to be long EXAS - hear their updated thoughts.

read more

Capital Brief: 5 Things to Watch Right Now In Washington

Here's a quick look at some key issues investors should keep an eye on from Hedgeye's JT Taylor and our team of Washington Policy analysts in D.C.

read more